APA
Rawson T. E., Rüth M., Blackwood E., Burdick D., Corson L., Dotson J., Drummond J., Fields C., Georges G. J., Goller B., Halladay J., Hunsaker T., Kleinheinz T., Krell H., Li J., Liang J., Limberg A., McNutt A., Moffat J., Phillips G., Ran Y., Safina B., Ultsch M., Walker L., Wiesmann C., Zhang B., Zhou A., Zhu B., Rüger P. & Cochran A. G. (20080908). A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability. : Journal of medicinal chemistry.
Chicago
Rawson Thomas E, Rüth Matthias, Blackwood Elizabeth, Burdick Dan, Corson Laura, Dotson Jenna, Drummond Jason, Fields Carter, Georges Guy J, Goller Bernhard, Halladay Jason, Hunsaker Thomas, Kleinheinz Tracy, Krell Hans-Willi, Li Jun, Liang Jun, Limberg Anja, McNutt Angela, Moffat John, Phillips Gail, Ran Yingqing, Safina Brian, Ultsch Mark, Walker Leslie, Wiesmann Christian, Zhang Birong, Zhou Aihe, Zhu Bing-Yan, Rüger Petra and Cochran Andrea G. 20080908. A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability. : Journal of medicinal chemistry.
Harvard
Rawson T. E., Rüth M., Blackwood E., Burdick D., Corson L., Dotson J., Drummond J., Fields C., Georges G. J., Goller B., Halladay J., Hunsaker T., Kleinheinz T., Krell H., Li J., Liang J., Limberg A., McNutt A., Moffat J., Phillips G., Ran Y., Safina B., Ultsch M., Walker L., Wiesmann C., Zhang B., Zhou A., Zhu B., Rüger P. and Cochran A. G. (20080908). A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability. : Journal of medicinal chemistry.
MLA
Rawson Thomas E, Rüth Matthias, Blackwood Elizabeth, Burdick Dan, Corson Laura, Dotson Jenna, Drummond Jason, Fields Carter, Georges Guy J, Goller Bernhard, Halladay Jason, Hunsaker Thomas, Kleinheinz Tracy, Krell Hans-Willi, Li Jun, Liang Jun, Limberg Anja, McNutt Angela, Moffat John, Phillips Gail, Ran Yingqing, Safina Brian, Ultsch Mark, Walker Leslie, Wiesmann Christian, Zhang Birong, Zhou Aihe, Zhu Bing-Yan, Rüger Petra and Cochran Andrea G. A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability. : Journal of medicinal chemistry. 20080908.